Cubist Systematic Strategies, LLC Oncocyte Corp Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.76 - $15.98 $10,243 - $215,378
13,478 Added 49.48%
40,718 $30,000
Q2 2022

Aug 15, 2022
BUY
$0.86 - $1.53 $23,426 - $41,677
27,240 New
27,240 $25,000
Q3 2021

Nov 15, 2021
SELL
$3.53 - $5.89 $47,270 - $78,872
-13,391 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.77 - $6.0 $54,446 - $86,652
-14,442 Reduced 51.89%
13,391 $77,000
Q1 2021

May 17, 2021
BUY
$2.39 - $6.5 $66,520 - $180,914
27,833 New
27,833 $144,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
399K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $260M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email